Search research articles
Contact Us
Filters
Showing results (121-130 of 278) with videos related to
Page
of 28
Sort By:
Journal of Global Antimicrobial Resistance
|
July 27, 2025
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus of diverse genetic types
Marisa L Winkler, John H Kimbrough, Helio S Sader, et al.
Antibiotics (Basel, Switzerland)
|
June 25, 2025
Activity of β-Lactamase Inhibitor Combinations Against Enterobacterales Isolated from Patients with Intra-Abdominal Infection from United States Medical Centres (2019-2023)
Helio S Sader, John H Kimbrough, Marisa L Winkler, et al.
Diagnostic Microbiology and Infectious Disease
|
November 25, 2010
Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program
Douglas J Biedenbach, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease
|
July 20, 2010
Worldwide summary of telavancin spectrum and potency against Gram-positive pathogens: 2007 to 2008 surveillance results
Shannon D Putnam, Helio S Sader, Gary J Moet, et al.
Antimicrobial Agents and Chemotherapy
|
June 15, 2011
LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from 56 medical centers in the United States
David J Farrell, Rodrigo E Mendes, James E Ross, et al.
Antimicrobial Agents and Chemotherapy
|
January 7, 2015
Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Journal of Clinical Microbiology
|
September 28, 2018
Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates
Helio S Sader, Paul R Rhomberg, Timothy B Doyle, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
October 28, 2009
Daptomycin activity tested against linezolid-nonsusceptible gram-positive clinical isolates
Rodrigo E Mendes, Ronald N Jones, Lalitagauri M Deshpande, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
October 14, 2003
Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY Antimicrobial Surveillance Program (1997-2000)
Rodrigo E Mendes, Adriana O Reis, Ana C Gales, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 21, 2012
Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections
Cesar A Arias, Rodrigo E Mendes, Matthew G Stilwell, et al.
Page
of 28
Search research articles
Search
Showing results (121-130 of 278) with videos related to
Sort By:
Page
of 28
Journal of Global Antimicrobial Resistance
|
July 27, 2025
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus of diverse genetic types
Marisa L Winkler, John H Kimbrough, Helio S Sader, et al.
Antibiotics (Basel, Switzerland)
|
June 25, 2025
Activity of β-Lactamase Inhibitor Combinations Against Enterobacterales Isolated from Patients with Intra-Abdominal Infection from United States Medical Centres (2019-2023)
Helio S Sader, John H Kimbrough, Marisa L Winkler, et al.
Diagnostic Microbiology and Infectious Disease
|
November 25, 2010
Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program
Douglas J Biedenbach, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease
|
July 20, 2010
Worldwide summary of telavancin spectrum and potency against Gram-positive pathogens: 2007 to 2008 surveillance results
Shannon D Putnam, Helio S Sader, Gary J Moet, et al.
Antimicrobial Agents and Chemotherapy
|
June 15, 2011
LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from 56 medical centers in the United States
David J Farrell, Rodrigo E Mendes, James E Ross, et al.
Antimicrobial Agents and Chemotherapy
|
January 7, 2015
Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States
Rodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Journal of Clinical Microbiology
|
September 28, 2018
Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates
Helio S Sader, Paul R Rhomberg, Timothy B Doyle, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
October 28, 2009
Daptomycin activity tested against linezolid-nonsusceptible gram-positive clinical isolates
Rodrigo E Mendes, Ronald N Jones, Lalitagauri M Deshpande, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
October 14, 2003
Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY Antimicrobial Surveillance Program (1997-2000)
Rodrigo E Mendes, Adriana O Reis, Ana C Gales, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 21, 2012
Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections
Cesar A Arias, Rodrigo E Mendes, Matthew G Stilwell, et al.
Page
of 28